Home Support ISMP Newsletters Webinars Report Medication Error to ISMP Educational Resources ISMP Online Store Consulting Services FAQ Tools and Resources About ISMP Contact Us
Print This Page SitemapISMP Facebook
Site Search by PicoSearch. Help

Textbook and Publication Errata

 

Error in Lexi-Comp publications within the monograph for hydromorphone dosing

Lexi-Comp has noted an error in their publications within the monograph for the dosing of hydromorphone.

The current field reads:
Pain:
Adults:

Oral, I.M., I.V., S.C.: 1-4 mg/dose every 4-6 hours as needed; usual adult dose: 2 mg/dose

Rectal: 3 mg every 6-8 hours

It should read:
Acute pain
(moderate to severe): Adults: Note: These are guidelines and do not represent the maximum doses that may be required in all patients. Doses should be titrated to pain relief/prevention.

Oral:

Initial: Opiate-naive: 2-4 mg every 3-4 hours as needed; patients with prior opiate exposure may require higher initial doses

Usual dosage range: 2-8 mg every 3-4 hours as needed

I.V.: Initial: Opiate-naive: 0.2-0.6 mg every 2-3 hours as needed; patients with prior opiate exposure may tolerate higher initial doses

Note: More frequent dosing may be needed.

Mechanically-ventilated patients (based on 70 kg patient): 0.7-2 mg every 1-2 hours as needed; infusion (based on 70 kg patient): 0.5-1 mg/hour

Patient-controlled analgesia (PCA): Initial: Opiate-naive: Consider lower end of dosing range; after loading: 0.05-0.4 mg/dose; usual lockout range: 5-10 minutes

Epidural: Initial: 0.8-1.5 mg/dose; infusion: 0.15-0.3 mg/hour

I.M., S.C.: Note: I.M. use may result in variable absorption and a lag time to peak effect.

Initial: Opiate-naive: 0.8-1 mg every 4-6 hours; patients with prior opiate exposure may require higher initial doses

Usual dosage range: 1-2 mg every 3-6 hours as needed

Rectal: 3 mg every 4-8 hours as needed

Chronic pain: Patients taking opioids chronically may become tolerant and require doses higher than the usual dosage range to maintain the desired effect. Tolerance can be managed by appropriate dose titration. There is no optimal or maximal dose for hydromorphone in chronic pain. The appropriate dose is one that relieves pain throughout its dosing interval without causing unmanageable side effects.

Home | Contact UsEmployment  | Legal Notices | Privacy Policy | Help Support ISMP
  Med-ERRS |   ISMP Canada |  ISMP Spain | ISMP Brasil | International Group | Pennsylvania Patient Safety Authority

200 Lakeside Drive, Suite 200, Horsham, PA 19044, Phone: (215) 947-7797,  Fax: (215) 914-1492
© 2012 Institute for Safe Medication Practices. All rights reserved

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.

Search only trustworthy HONcode health websites: